- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 96 | 1.05 | 1.05 | 1.03 | -63.35 | -70.06 | 2.66 | 232.5 | 76.16 | 8.09 | 14.75 | -14.21 | 12.32 | 5.93 | 23.08 | 47.74 | 11.67 | 2.38 | 25.31 | 84.61 | 17.72 | 8.12 | -66.15 | -76.02 | 3.12 | 96.23 | 45.12 | 0.99 | -63.06 | -69.82 | 12.62 | -58.06 | -68.28 | 8.12 | -66.15 | -76.02 | 6.90 | -48.54 | 143.18 |
| 24Q2 (19) | 95 | 0.0 | 0.0 | 2.81 | -33.73 | 54.4 | 0.80 | 53.85 | 142.42 | 7.05 | 66.27 | 17.5 | 11.63 | 7.88 | -2.1 | 42.75 | 9.67 | 20.76 | 13.71 | 18.29 | 5.46 | 23.99 | -37.74 | 72.22 | 1.59 | 27.2 | 3.25 | 2.68 | -33.66 | 54.02 | 30.09 | -32.2 | 20.46 | 23.99 | -37.74 | 72.22 | 3.94 | 104.11 | -7.60 |
| 24Q1 (18) | 95 | 0.0 | 0.0 | 4.24 | 241.94 | 1.68 | 0.52 | -69.05 | -84.43 | 4.24 | -60.26 | 1.68 | 10.78 | 0.0 | -30.0 | 38.98 | -8.22 | -17.5 | 11.59 | -32.58 | -56.8 | 38.53 | 182.27 | 47.74 | 1.25 | -32.43 | -69.73 | 4.04 | 242.37 | 1.51 | 44.38 | 235.96 | 39.3 | 38.53 | 182.27 | 47.74 | 3.85 | 89.00 | -28.89 |
| 23Q4 (17) | 95 | 0.0 | 1.06 | 1.24 | -63.95 | -70.55 | 1.68 | 11.26 | -58.82 | 10.67 | 13.15 | -70.39 | 10.78 | 7.69 | -40.51 | 42.47 | -8.92 | -19.26 | 17.19 | -20.05 | -35.81 | 13.65 | -59.69 | -39.39 | 1.85 | -13.95 | -61.86 | 1.18 | -64.02 | -70.13 | 13.21 | -66.8 | -50.95 | 13.65 | -59.69 | -39.39 | -4.03 | 12.53 | 184.42 |
| 23Q3 (16) | 95 | 0.0 | 1.06 | 3.44 | 89.01 | -59.62 | 1.51 | 357.58 | -79.87 | 9.43 | 57.17 | -70.49 | 10.01 | -15.74 | -58.2 | 46.63 | 31.72 | -10.57 | 21.50 | 65.38 | -45.35 | 33.86 | 143.07 | -0.53 | 2.15 | 39.61 | -77.18 | 3.28 | 88.51 | -59.1 | 39.79 | 59.29 | -6.97 | 33.86 | 143.07 | -0.53 | -19.30 | 16.33 | 133.73 |
| 23Q2 (15) | 95 | 0.0 | 2.15 | 1.82 | -56.35 | -89.13 | 0.33 | -90.12 | -97.93 | 6.00 | 43.88 | -74.41 | 11.88 | -22.86 | -67.25 | 35.40 | -25.08 | -48.06 | 13.00 | -51.55 | -76.55 | 13.93 | -46.59 | -68.63 | 1.54 | -62.71 | -92.34 | 1.74 | -56.28 | -88.87 | 24.98 | -21.59 | -55.73 | 13.93 | -46.59 | -68.63 | -18.93 | -28.65 | -54.13 |
| 23Q1 (14) | 95 | 1.06 | 2.15 | 4.17 | -0.95 | -37.67 | 3.34 | -18.14 | -37.92 | 4.17 | -88.43 | -37.67 | 15.4 | -15.01 | -14.11 | 47.25 | -10.17 | -12.86 | 26.83 | 0.19 | -31.5 | 26.08 | 15.81 | -26.33 | 4.13 | -14.85 | -41.17 | 3.98 | 0.76 | -36.12 | 31.86 | 18.31 | -29.42 | 26.08 | 15.81 | -26.33 | -19.68 | -25.77 | -31.87 |
| 22Q4 (13) | 94 | 0.0 | 1.08 | 4.21 | -50.59 | 37.58 | 4.08 | -45.6 | 119.35 | 36.03 | 12.77 | 68.76 | 18.12 | -24.34 | 32.26 | 52.60 | 0.88 | 36.34 | 26.78 | -31.93 | 38.33 | 22.52 | -33.84 | 4.4 | 4.85 | -48.51 | 83.02 | 3.95 | -50.75 | 39.58 | 26.93 | -37.04 | -0.22 | 22.52 | -33.84 | 4.4 | -29.16 | -49.86 | -49.23 |
| 22Q3 (12) | 94 | 1.08 | 1.08 | 8.52 | -49.13 | 34.81 | 7.50 | -52.86 | 15.56 | 31.95 | 36.25 | 74.49 | 23.95 | -33.99 | 14.1 | 52.14 | -23.5 | -5.95 | 39.34 | -29.04 | -1.67 | 34.04 | -23.35 | 16.5 | 9.42 | -53.16 | 12.14 | 8.02 | -48.69 | 36.86 | 42.77 | -24.21 | 11.85 | 34.04 | -23.35 | 16.5 | 34.17 | 50.62 | 71.43 |
| 22Q2 (11) | 93 | 0.0 | 1.09 | 16.75 | 150.37 | 147.78 | 15.91 | 195.72 | 215.67 | 23.45 | 250.52 | 95.58 | 36.28 | 102.34 | 116.21 | 68.16 | 25.71 | 25.48 | 55.44 | 41.54 | 46.24 | 44.41 | 25.45 | 15.41 | 20.11 | 186.47 | 216.19 | 15.63 | 150.88 | 150.88 | 56.43 | 25.01 | 22.14 | 44.41 | 25.45 | 15.41 | 66.61 | 134.50 | 192.49 |
| 22Q1 (10) | 93 | 0.0 | 1.09 | 6.69 | 118.63 | 27.67 | 5.38 | 189.25 | 90.11 | 6.69 | -68.67 | 27.67 | 17.93 | 30.88 | 33.11 | 54.22 | 40.54 | 20.57 | 39.17 | 102.32 | 48.99 | 35.40 | 64.12 | -2.67 | 7.02 | 164.91 | 98.31 | 6.23 | 120.14 | 29.25 | 45.14 | 67.25 | 7.71 | 35.40 | 64.12 | -2.67 | -1.92 | 33.52 | 58.95 |
| 21Q4 (9) | 93 | 0.0 | 4.49 | 3.06 | -51.58 | -3.47 | 1.86 | -71.34 | -38.0 | 21.35 | 16.6 | 25.0 | 13.7 | -34.73 | -2.42 | 38.58 | -30.41 | -9.18 | 19.36 | -51.61 | -28.59 | 21.57 | -26.18 | 4.35 | 2.65 | -68.45 | -30.45 | 2.83 | -51.71 | 0.35 | 26.99 | -29.42 | 1.09 | 21.57 | -26.18 | 4.35 | -4.82 | -29.04 | -21.29 |
| 21Q3 (8) | 93 | 1.09 | 1.09 | 6.32 | -6.51 | 61.22 | 6.49 | 28.77 | 70.34 | 18.31 | 52.71 | 30.14 | 20.99 | 25.09 | 40.59 | 55.44 | 2.06 | 18.66 | 40.01 | 5.54 | 27.54 | 29.22 | -24.06 | 17.54 | 8.4 | 32.08 | 79.49 | 5.86 | -5.94 | 63.23 | 38.24 | -17.23 | 23.79 | 29.22 | -24.06 | 17.54 | 24.83 | 11.25 | 53.43 |
| 21Q2 (7) | 92 | 0.0 | 4.55 | 6.76 | 29.01 | 12.67 | 5.04 | 78.09 | -10.95 | 11.99 | 128.82 | 17.55 | 16.78 | 24.57 | -3.73 | 54.32 | 20.79 | -6.15 | 37.91 | 44.2 | -9.95 | 38.48 | 5.8 | 22.16 | 6.36 | 79.66 | -13.35 | 6.23 | 29.25 | 17.55 | 46.20 | 10.24 | 11.7 | 38.48 | 5.8 | 22.16 | 10.26 | 47.16 | 36.21 |
| 21Q1 (6) | 92 | 3.37 | 9.52 | 5.24 | 65.3 | 26.27 | 2.83 | -5.67 | -15.52 | 5.24 | -69.32 | 26.27 | 13.47 | -4.06 | 6.57 | 44.97 | 5.86 | -12.34 | 26.29 | -3.02 | -16.7 | 36.37 | 75.96 | 25.33 | 3.54 | -7.09 | -11.28 | 4.82 | 70.92 | 37.71 | 41.91 | 56.97 | 24.1 | 36.37 | 75.96 | 25.33 | -5.01 | 23.09 | -13.46 |
| 20Q4 (5) | 89 | -3.26 | 7.23 | 3.17 | -19.13 | 5.32 | 3.00 | -21.26 | 20.97 | 17.08 | 21.39 | 112.7 | 14.04 | -5.96 | 22.83 | 42.48 | -9.08 | -6.18 | 27.11 | -13.58 | 15.66 | 20.67 | -16.85 | -6.43 | 3.81 | -18.59 | 42.16 | 2.82 | -21.45 | 13.71 | 26.70 | -13.56 | 10.01 | 20.67 | -16.85 | -6.43 | - | - | 0.00 |
| 20Q3 (4) | 92 | 4.55 | 0.0 | 3.92 | -34.67 | 0.0 | 3.81 | -32.69 | 0.0 | 14.07 | 37.94 | 0.0 | 14.93 | -14.34 | 0.0 | 46.72 | -19.28 | 0.0 | 31.37 | -25.49 | 0.0 | 24.86 | -21.08 | 0.0 | 4.68 | -36.24 | 0.0 | 3.59 | -32.26 | 0.0 | 30.89 | -25.31 | 0.0 | 24.86 | -21.08 | 0.0 | - | - | 0.00 |
| 20Q2 (3) | 88 | 4.76 | 0.0 | 6.00 | 44.58 | 0.0 | 5.66 | 68.96 | 0.0 | 10.20 | 145.78 | 0.0 | 17.43 | 37.9 | 0.0 | 57.88 | 12.83 | 0.0 | 42.10 | 33.4 | 0.0 | 31.50 | 8.55 | 0.0 | 7.34 | 83.96 | 0.0 | 5.3 | 51.43 | 0.0 | 41.36 | 22.48 | 0.0 | 31.50 | 8.55 | 0.0 | - | - | 0.00 |
| 20Q1 (2) | 84 | 1.2 | 0.0 | 4.15 | 37.87 | 0.0 | 3.35 | 35.08 | 0.0 | 4.15 | -48.32 | 0.0 | 12.64 | 10.59 | 0.0 | 51.30 | 13.3 | 0.0 | 31.56 | 34.64 | 0.0 | 29.02 | 31.37 | 0.0 | 3.99 | 48.88 | 0.0 | 3.5 | 41.13 | 0.0 | 33.77 | 39.14 | 0.0 | 29.02 | 31.37 | 0.0 | - | - | 0.00 |
| 19Q4 (1) | 83 | 0.0 | 0.0 | 3.01 | 0.0 | 0.0 | 2.48 | 0.0 | 0.0 | 8.03 | 0.0 | 0.0 | 11.43 | 0.0 | 0.0 | 45.28 | 0.0 | 0.0 | 23.44 | 0.0 | 0.0 | 22.09 | 0.0 | 0.0 | 2.68 | 0.0 | 0.0 | 2.48 | 0.0 | 0.0 | 24.27 | 0.0 | 0.0 | 22.09 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 3.95 | -10.61 | 1.76 | 38.69 | -6.02 | 12.13 | N/A | - | ||
| 2024/9 | 4.42 | 17.49 | 20.88 | 34.74 | -6.83 | 12.32 | 0.98 | - | ||
| 2024/8 | 3.76 | -9.24 | 25.92 | 30.32 | -9.84 | 11.81 | 1.02 | - | ||
| 2024/7 | 4.14 | 5.88 | 23.09 | 26.56 | -13.32 | 11.85 | 1.01 | - | ||
| 2024/6 | 3.91 | 2.98 | -0.28 | 22.42 | -17.82 | 11.63 | 1.01 | - | ||
| 2024/5 | 3.8 | -3.17 | -18.47 | 18.51 | -20.76 | 11.44 | 1.03 | - | ||
| 2024/4 | 3.92 | 5.41 | 17.54 | 14.71 | -21.33 | 10.51 | 1.12 | - | ||
| 2024/3 | 3.72 | 30.13 | -9.7 | 10.78 | -29.78 | 10.78 | 1.09 | - | ||
| 2024/2 | 2.86 | -31.92 | -34.99 | 7.06 | -37.15 | 10.41 | 1.13 | - | ||
| 2024/1 | 4.2 | 25.29 | -38.54 | 4.2 | -38.54 | 11.11 | 1.06 | - | ||
| 2023/12 | 3.35 | -5.6 | -30.61 | 48.07 | -50.06 | 10.78 | 1.12 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售減少 | ||
| 2023/11 | 3.55 | -8.45 | -14.07 | 44.72 | -51.09 | 11.09 | 1.09 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售減少 | ||
| 2023/10 | 3.88 | 6.17 | -57.59 | 41.16 | -52.84 | 10.52 | 1.15 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售減少 | ||
| 2023/9 | 3.65 | 22.38 | -42.53 | 37.28 | -52.29 | 10.01 | 1.3 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售減少 | ||
| 2023/8 | 2.99 | -11.28 | -45.91 | 33.63 | -53.15 | 10.27 | 1.26 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售減少 | ||
| 2023/7 | 3.37 | -14.21 | -72.1 | 30.64 | -53.75 | 11.95 | 1.09 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售減少 | ||
| 2023/6 | 3.92 | -15.79 | -66.77 | 27.28 | -49.67 | 11.92 | 1.06 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售減少 | ||
| 2023/5 | 4.66 | 39.59 | -61.39 | 23.36 | -44.91 | 12.12 | 1.04 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售減少 | ||
| 2023/4 | 3.34 | -19.02 | -73.08 | 18.7 | -38.35 | 11.86 | 1.07 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售減少 | ||
| 2023/3 | 4.12 | -6.31 | -27.24 | 15.36 | -14.33 | 15.36 | 0.96 | - | ||
| 2023/2 | 4.4 | -35.64 | -8.69 | 11.24 | -8.37 | 16.07 | 0.91 | - | ||
| 2023/1 | 6.84 | 41.47 | -8.16 | 6.84 | -8.16 | 15.8 | 0.93 | - | ||
| 2022/12 | 4.83 | 16.89 | 8.63 | 96.27 | 48.25 | 18.12 | 0.9 | - | ||
| 2022/11 | 4.13 | -54.82 | -20.82 | 91.44 | 51.17 | 19.64 | 0.83 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售增加 | ||
| 2022/10 | 9.15 | 43.9 | 127.2 | 87.3 | 57.97 | 21.03 | 0.77 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售增加 | ||
| 2022/9 | 6.36 | 15.18 | -4.76 | 78.15 | 52.53 | 23.95 | 0.73 | 本年係因新冠肺炎抗原快篩檢驗試劑銷售增加 | ||
| 2022/8 | 5.52 | -54.24 | -24.57 | 71.79 | 61.11 | 29.39 | 0.59 | 因新冠肺炎抗原快篩檢驗試劑銷售減少 | ||
| 2022/7 | 12.07 | 2.19 | 72.45 | 66.27 | 77.96 | 35.94 | 0.49 | 因新冠肺炎抗原快篩檢驗試劑銷售增加 | ||
| 2022/6 | 11.81 | -2.16 | 30.83 | 54.21 | 79.23 | 36.28 | 0.57 | 因新冠肺炎抗原快篩檢驗試劑銷售增加 | ||
| 2022/5 | 12.07 | -2.68 | 171.06 | 42.4 | 99.81 | 30.14 | 0.69 | 因新冠肺炎抗原快篩檢驗試劑銷售增加 | ||
| 2022/4 | 12.4 | 118.89 | 275.69 | 30.33 | 80.89 | 22.89 | 0.91 | 因新冠肺炎抗原快篩檢驗試劑銷售增加 | ||
| 2022/3 | 5.67 | 17.57 | 31.04 | 17.93 | 33.14 | 17.93 | 0.86 | - | ||
| 2022/2 | 4.82 | -35.27 | 25.38 | 12.26 | 34.13 | 16.71 | 0.92 | - | ||
| 2022/1 | 7.44 | 67.35 | 40.48 | 7.44 | 40.48 | 17.11 | 0.9 | - | ||
| 2021/12 | 4.45 | -14.79 | -21.26 | 64.93 | 10.15 | 13.7 | 1.05 | - | ||
| 2021/11 | 5.22 | 29.62 | 35.73 | 60.48 | 13.48 | 15.93 | 0.91 | - | ||
| 2021/10 | 4.03 | -39.68 | -9.57 | 55.26 | 11.75 | 18.02 | 0.8 | - | ||
| 2021/9 | 6.68 | -8.76 | 22.75 | 51.24 | 13.86 | 20.99 | 0.7 | - | ||
| 2021/8 | 7.32 | 4.61 | 69.1 | 44.56 | 12.64 | 23.34 | 0.63 | 因新冠肺炎抗原快篩檢驗試劑銷售增加 | ||
| 2021/7 | 7.0 | -22.47 | 34.32 | 37.24 | 5.7 | 20.47 | 0.72 | - | ||
| 2021/6 | 9.02 | 102.68 | 93.22 | 30.24 | 0.74 | 16.78 | 0.88 | 因新冠肺炎抗原快篩檢驗試劑銷售增加 | ||
| 2021/5 | 4.45 | 34.88 | -30.03 | 21.22 | -16.29 | 12.08 | 1.22 | - | ||
| 2021/4 | 3.3 | -23.65 | -48.0 | 16.77 | -11.69 | 11.47 | 1.29 | - | ||
| 2021/3 | 4.32 | 12.5 | -17.19 | 13.47 | 6.54 | 13.47 | 1.11 | - | ||
| 2021/2 | 3.84 | -27.47 | -6.82 | 9.14 | 23.24 | 14.79 | 1.01 | - | ||
| 2021/1 | 5.3 | -6.2 | 60.91 | 5.3 | 60.91 | 14.79 | 1.01 | 因新冠肺炎額溫槍銷售增加 | ||
| 2020/12 | 5.65 | 46.88 | 23.88 | 58.95 | 42.29 | 13.95 | 1.09 | - | ||
| 2020/11 | 3.85 | -13.64 | 3.83 | 53.3 | 44.57 | 13.74 | 1.11 | - | ||
| 2020/10 | 4.45 | -18.11 | 35.55 | 49.45 | 49.12 | 14.22 | 1.07 | - | ||
| 2020/9 | 5.44 | 25.67 | 102.97 | 45.0 | 50.61 | 14.98 | 1.01 | 因武漢肺炎額溫銷售增加 | ||
| 2020/8 | 4.33 | -16.89 | 21.03 | 39.56 | 45.45 | 14.21 | 1.07 | - | ||
| 2020/7 | 5.21 | 11.52 | 38.66 | 35.23 | 49.15 | 16.24 | 0.93 | - | ||
| 2020/6 | 4.67 | -26.6 | 40.04 | 30.02 | 51.14 | 17.38 | 0.84 | 因武漢肺炎額溫槍銷售增加 | ||
| 2020/5 | 6.36 | 0.23 | 83.83 | 25.35 | 53.38 | 17.93 | 0.81 | 因武漢肺炎額溫槍銷售增加 | ||
| 2020/4 | 6.35 | 21.59 | 105.13 | 18.99 | 45.31 | 15.69 | 0.93 | 因武漢肺炎額溫槍銷售増加 | ||
| 2020/3 | 5.22 | 26.58 | 47.64 | 12.64 | 26.74 | 12.64 | 0.86 | - | ||
| 2020/2 | 4.12 | 25.24 | 55.68 | 7.42 | 15.26 | 11.98 | 0.91 | 因武漢肺炎額溫槍銷售增加 | ||
| 2020/1 | 3.29 | -27.78 | -13.02 | 3.29 | -13.02 | 11.56 | 0.94 | - | ||
| 2019/12 | 4.56 | 23.1 | 11.61 | 41.42 | -4.69 | 0.0 | N/A | - | ||
| 2019/11 | 3.7 | 12.73 | -10.51 | 36.86 | -6.39 | 0.0 | N/A | - |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 95 | 1.06 | 10.62 | -69.74 | 6.84 | -79.18 | 48.07 | -50.07 | 43.12 | -26.48 | 20.14 | -53.17 | 21.90 | -39.22 | 9.68 | -76.62 | 13.28 | -69.6 | 10.17 | -69.94 |
| 2022 (9) | 94 | 1.08 | 35.10 | 70.31 | 32.86 | 102.46 | 96.27 | 48.27 | 58.65 | 18.68 | 43.01 | 33.28 | 36.03 | 14.45 | 41.41 | 97.66 | 43.69 | 73.93 | 33.83 | 71.29 |
| 2021 (8) | 93 | 4.49 | 20.61 | 25.98 | 16.23 | 2.59 | 64.93 | 9.98 | 49.42 | -1.14 | 32.27 | -3.87 | 31.48 | 17.81 | 20.95 | 5.7 | 25.12 | 26.61 | 19.75 | 29.85 |
| 2020 (7) | 89 | 7.23 | 16.36 | 115.55 | 15.82 | 139.7 | 59.04 | 42.68 | 49.99 | 13.05 | 33.57 | 73.04 | 26.72 | 62.63 | 19.82 | 146.82 | 19.84 | 138.18 | 15.21 | 129.07 |
| 2019 (6) | 83 | 5.06 | 7.59 | -27.85 | 6.60 | -17.19 | 41.38 | -4.81 | 44.22 | -2.83 | 19.40 | -14.54 | 16.43 | -20.55 | 8.03 | -18.64 | 8.33 | -24.13 | 6.64 | -24.29 |
| 2018 (5) | 79 | 1.28 | 10.52 | 105.07 | 7.97 | 71.4 | 43.47 | 29.96 | 45.51 | 4.62 | 22.70 | 19.79 | 20.68 | 52.28 | 9.87 | 55.68 | 10.98 | 79.41 | 8.77 | 106.35 |
| 2017 (4) | 78 | 4.0 | 5.13 | -20.83 | 4.65 | -11.76 | 33.45 | 6.26 | 43.50 | -6.23 | 18.95 | -5.06 | 13.58 | -14.81 | 6.34 | 0.79 | 6.12 | 0.0 | 4.25 | -13.09 |
| 2016 (3) | 75 | 8.7 | 6.48 | 8.0 | 5.27 | 23.71 | 31.48 | 19.38 | 46.39 | 0.67 | 19.96 | 12.51 | 15.94 | -3.8 | 6.29 | 34.4 | 6.12 | 21.43 | 4.89 | 9.89 |
| 2015 (2) | 69 | 6.15 | 6.00 | -0.5 | 4.26 | 2.4 | 26.37 | 4.6 | 46.08 | 4.11 | 17.74 | -5.79 | 16.57 | 1.22 | 4.68 | -1.47 | 5.04 | 0.0 | 4.45 | 3.97 |
| 2014 (1) | 65 | 3.17 | 6.03 | 15.52 | 4.16 | 87.39 | 25.21 | 9.42 | 44.26 | 0 | 18.83 | 0 | 16.37 | 0 | 4.75 | 100.42 | 5.04 | 36.96 | 4.28 | 24.78 |
